Multiple Sclerosis, Relapsing-Remitting
"Multiple Sclerosis, Relapsing-Remitting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)
MeSH Number(s)
C10.114.375.500.600
C10.314.350.500.600
C20.111.258.250.500.600
Concept/Terms
Multiple Sclerosis, Relapsing-Remitting- Multiple Sclerosis, Relapsing-Remitting
- Multiple Sclerosis, Relapsing Remitting
- Remitting-Relapsing Multiple Sclerosis
- Multiple Sclerosis, Remitting-Relapsing
- Remitting Relapsing Multiple Sclerosis
- Relapsing-Remitting Multiple Sclerosis
- Relapsing Remitting Multiple Sclerosis
Below are MeSH descriptors whose meaning is more general than "Multiple Sclerosis, Relapsing-Remitting".
Below are MeSH descriptors whose meaning is more specific than "Multiple Sclerosis, Relapsing-Remitting".
This graph shows the total number of publications written about "Multiple Sclerosis, Relapsing-Remitting" by people in Harvard Catalyst Profiles by year, and whether "Multiple Sclerosis, Relapsing-Remitting" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 2 | 1 | 3 |
| 2000 | 5 | 2 | 7 |
| 2001 | 4 | 0 | 4 |
| 2002 | 5 | 1 | 6 |
| 2003 | 6 | 2 | 8 |
| 2004 | 7 | 0 | 7 |
| 2005 | 6 | 2 | 8 |
| 2006 | 4 | 0 | 4 |
| 2007 | 8 | 2 | 10 |
| 2008 | 10 | 1 | 11 |
| 2009 | 11 | 2 | 13 |
| 2010 | 5 | 0 | 5 |
| 2011 | 11 | 1 | 12 |
| 2012 | 14 | 0 | 14 |
| 2013 | 8 | 3 | 11 |
| 2014 | 6 | 2 | 8 |
| 2015 | 16 | 4 | 20 |
| 2016 | 21 | 0 | 21 |
| 2017 | 10 | 0 | 10 |
| 2018 | 13 | 0 | 13 |
| 2019 | 12 | 2 | 14 |
| 2020 | 12 | 0 | 12 |
Below are the most recent publications written about "Multiple Sclerosis, Relapsing-Remitting" by people in Profiles.
-
Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years. Neurology. 2021 02 02; 96(5):e783-e797.
-
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study. Mult Scler Relat Disord. 2021 Feb; 48:102690.
-
7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis. Brain. 2020 10 01; 143(10):2973-2987.
-
Spiral MRSI and tissue segmentation of normal-appearing white matter and white matter lesions in relapsing remitting multiple sclerosis patients?. Magn Reson Imaging. 2020 12; 74:21-30.
-
GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis. Neurology. 2020 09 01; 95(9):399-401.
-
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis. J Neuroinflammation. 2020 Jun 15; 17(1):189.
-
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic. Mult Scler Relat Disord. 2020 08; 43:102222.
-
Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT. Neurology. 2020 05 05; 94(18):e1950-e1960.
-
Gait changes following direct versus contralateral strength training: A randomized controlled pilot study in individuals with multiple sclerosis. Gait Posture. 2020 05; 78:13-18.
-
Blood neurofilament light levels segregate treatment effects in multiple sclerosis. Neurology. 2020 03 17; 94(11):e1201-e1212.